Imaging Technology

SEPTEMBER 29, 2023

milla1cf Fri, 09/29/2023 - 17:00 September 29, 2023 — People with intermediate risk, localized prostate cancer can be treated as effectively using fewer and higher doses of radiation therapy delivered over five treatment sessions as they can with lower doses delivered over several weeks, a new phase III randomized trial suggests.

Radiation 92

Radiation Radiation Oncology Disease Diagnose 92

Imaging Technology

APRIL 29, 2024

a professor in Radiation Oncology at the Montefiore Einstein Comprehensive Cancer Center , aims to demonstrate the feasibility of PGHD collection during proton beam radiotherapy for lung cancer. These adverse events often lead to hospitalizations and treatment interruptions that can reduce treatment efficacy.

Radiation Oncology 111

Radiation Oncology Radiation Hospital Healthcare 111

Imaging Technology

SEPTEMBER 27, 2023

milla1cf Wed, 09/27/2023 - 15:07 September 27, 2023 — The American Society for Radiation Oncology ( ASTRO ) announced the three winning research proposals for the 2022 ASTRO-Myovant Sciences (now known as Sumitomo Pharma)-Pfizer Alliance New Combination (Relugolix-Radiation) Therapy Challenge.

Radiation 101

Radiation Radiation Oncology Clinic Disease 101

Imaging Technology

MAY 24, 2024

The research team is using the grant to analyze previous and current advanced practice radiation therapist (APRT) training programs internationally and to identify an evidence-based, best-practice framework for APRT education in the U.S. and Canada. The APRT role practices at an advanced level in radiation therapy. or Canada. “The

Radiology Technologist 64

Radiology Technologist Radiation Radiation Science Education 64

Imaging Technology

SEPTEMBER 27, 2023

“PET imaging with POSLUMA reveals clinical information crucial to decision-making for men with prostate cancer, and we are excited to share further information with the radiation oncology community at ASTRO 2023,” said David E. POSLUMA use contributes to a patient’s overall long-term cumulative radiation exposure.

Diagnostic 100

Diagnostic Radiation Oncology Radiation Clinic 100

Imaging Technology

OCTOBER 1, 2023

Participants can book demonstrations of RayStation treatment planning system, RayCare oncology information system, and cloud-based oncology analytics system RayIntelligence , in RaySearchs’s booth 3245 during the event.

Radiation Oncology 52

Radiation Oncology DICOM Radiation Clinic 52

AuntMinnie

JULY 12, 2024

Thrombocytopenia – low blood platelets – is a relatively common adverse event of PRRT and often limits patients from a full course of therapy. Previous treatment exposures included alkylating agents in 30%, platinum agents in 8%, and external radiation in 13%. The median age of the patients was 68 and 51.4%

Radiation 59

Radiation IT Radiation Oncology Clinic 59

AuntMinnie

MARCH 26, 2024

The L block lead shield over the syringe helps protect certified nuclear medicine technologist James Johnson (left), and nuclear radiologist Penny Vroman, MD (right), from radiation emitted by the drug. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

Imaging Technology

JULY 10, 2023

The July 9-12 event is being held in Indianapolis, Ind., Winter, PhD, FAHRA, CRA, RDMS, RVT, RT(R) , is Director of Radiology and Patient Transportation at John Peter Smith Health Network (Cleburne, Texas) Sharon Harms, CRA, FAHRA , Director of Radiology, Radiation Oncology and GI Specialties for Bryan Medical Center (Lincoln, Neb.)

Radiation Oncology 67

Radiation Oncology Radiology Technologist Hospital Healthcare 67

AuntMinnie

JUNE 20, 2024

The L block lead shield over the syringe helps protect certified nuclear medicine technologist James Johnson (left), and nuclear radiologist Penny Vroman, MD (right), from radiation emitted by the drug. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

Imaging Technology

OCTOBER 5, 2023

We are pleased to present these results from the LIGHTHOUSE study to the radiation oncology community at ASTRO,” said David E. No serious adverse events were observed in the LIGHTHOUSE study. The most frequently reported adverse event for patients in the LIGHTHOUSE study was injection site pain among 0.8% (3/356) of patients.

Diagnose 52

Diagnose Diagnostic Disease Radiation 52

Imaging Technology

SEPTEMBER 7, 2023

milla1cf Thu, 09/07/2023 - 13:57 September 7, 2023 — American Society for Radiation Oncology (ASTRO) President Jeff Michalski, MD, MBA, FASTRO , will join today’s first stakeholder meeting of the President’s Cancer Panel , part of the National Cancer Plan to end cancer as we know it.

Radiation 64

Radiation Radiation Oncology Medicare Clinic 64

Imaging Technology

OCTOBER 1, 2023

The MAGNETOM Free.Max RT Edition* is the latest addition to the Siemens Healthineers Magnetic Resonance (MR) imaging portfolio for radiation therapy – the key to personalized RT. Cancer care is complex, and providers worldwide are forced to navigate the challenges of fragmented healthcare delivery systems. FDA 510(k) pending.

Radiation Oncology 52

Radiation Oncology Radiation Communication Imaging 52